Abstract
The use of liposome-encapsulated hemoglobin (LHb), which is a cellular Hb, has been demonstrated to be beneficial in the treatment of hypohemoglobinemic shock. As a molecule of appropriate size (220 nm) that can carry oxygen, LHb may ameliorate cardiac dysfunction during lethal hemodilation. The purpose of this study was to determine the efficacy of LHb transfusion in relieving cardiovascular dysfunction in a rat model of lethal progressive hemodilution. Over the course of 150 min, rats were subjected to blood withdrawal (0.2 mL/min) and simultaneously transfused with LHb, washed rat red blood cells, or 5% albumin. Temporal changes in cardiac function, heart-type fatty acid-binding protein levels, plasma levels of catecholamines, heart rate variability, and hypoxia-inducible factor 1α expression were measured during lethal progressive hemodilution. More than 80% of the rats transfused with either LHb or washed rat red blood cells survived for 8 days. Liposome-encapsulated hemoglobin transfusion suppressed hypoxia-inducible factor 1α expression in the heart, maintained low levels of heart-type fatty acid-binding protein, and attenuated sympathetic nerve activity as reflected by changes in heart rate variability and plasma levels...Continue Reading
References
Aug 1, 1991·Circulation·A MallianiS Cerutti
Apr 1, 1991·Clinical Biochemistry·T TanakaK Kawamura
Jul 1, 1989·Circulation·D W FergusonM G Kienzle
Oct 1, 1989·Circulation Research·A A KnowltonP Brecher
Aug 1, 1986·Circulation Research·M PaganiE Piccaluga
Dec 1, 1986·Circulation·D J GordonH A Tyroler
May 1, 1987·Journal of Molecular and Cellular Cardiology·T S CrismanP Brecher
Apr 1, 1967·Physiological Reviews·S Chien
Jul 10, 1981·Science·S AkselrodR J Cohen
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Jul 1, 1997·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Y OgataH Fukui
Mar 25, 1998·Journal of Biomedical Materials Research·H SakaiM Intaglietta
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L E HuangH F Bunn
Jul 14, 1998·Nature Biotechnology·D H DohertyD D Lemon
Oct 24, 1998·Surgery Today·A UsubaH Fukui
Dec 10, 1999·Shock·J A KlineJ A Watts
Dec 22, 1999·Biochemical Pharmacology·G L Semenza
Oct 14, 2003·Journal of Applied Physiology·Marvin O BoluytMark W Russell
Feb 6, 2004·Critical Care Medicine·Hiromi SakaiEishun Tsuchida
Mar 3, 2004·Journal of the American College of Surgeons·A Gerson GreenburgUNKNOWN Hemolink Study Group
Mar 27, 2004·Nature Reviews. Drug Discovery·Abdu I Alayash
Jun 18, 2004·Shock·Maha AbdelrahmanChristoph Thiemermann
Aug 17, 2004·Journal of Artificial Organs : the Official Journal of the Japanese Society for Artificial Organs·Teiji OdaYutaka Fujise
Sep 18, 2004·Blood·Dominador J ManaloGregg L Semenza
Feb 28, 2006·Journal of Molecular and Cellular Cardiology·Shaolong YangIrshad H Chaudry
May 20, 2006·World Journal of Surgery·Ernest E MooreJeffrey L Johnson
Jun 5, 2007·Shock·Hiroaki SatoNoriyuki Tanaka
Apr 30, 2008·JAMA : the Journal of the American Medical Association·Charles NatansonSidney M Wolfe
Jul 25, 2008·Annals of Surgery·Yashiro NogamiTadaaki Maehara
Feb 21, 2009·Journal of the American College of Surgeons·Ernest E MooreUNKNOWN PolyHeme Study Group
Jul 6, 2010·Shock·Satoshi ShonoShuhji Seki